- Home
- USEA vs AEON Comparison
USEA vs AEON Comparison
Compare USEA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- AEON
- Stock Information
- Founded
- USEA 2004
- AEON N/A
- Country
- USEA Greece
- AEON United States
- Employees
- USEA N/A
- AEON N/A
- Industry
- USEA Marine Transportation
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- USEA Consumer Discretionary
- AEON Health Care
- Exchange
- USEA Nasdaq
- AEON Nasdaq
- Market Cap
- USEA 15.6M
- AEON 13.5M
- IPO Year
- USEA N/A
- AEON N/A
- Fundamental
- Price
- USEA $1.53
- AEON $0.94
- Analyst Decision
- USEA
- AEON Strong Buy
- Analyst Count
- USEA 0
- AEON 1
- Target Price
- USEA N/A
- AEON $7.20
- AVG Volume (30 Days)
- USEA 25.1K
- AEON 396.3K
- Earning Date
- USEA 11-25-2025
- AEON 11-12-2025
- Dividend Yield
- USEA 2.65%
- AEON N/A
- EPS Growth
- USEA N/A
- AEON N/A
- EPS
- USEA N/A
- AEON N/A
- Revenue
- USEA $42,625,000.00
- AEON N/A
- Revenue This Year
- USEA N/A
- AEON N/A
- Revenue Next Year
- USEA N/A
- AEON N/A
- P/E Ratio
- USEA N/A
- AEON N/A
- Revenue Growth
- USEA N/A
- AEON N/A
- 52 Week Low
- USEA $1.00
- AEON $0.38
- 52 Week High
- USEA $2.36
- AEON $66.20
- Technical
- Relative Strength Index (RSI)
- USEA 30.93
- AEON 50.47
- Support Level
- USEA $1.61
- AEON $0.83
- Resistance Level
- USEA $1.69
- AEON $0.96
- Average True Range (ATR)
- USEA 0.05
- AEON 0.13
- MACD
- USEA -0.01
- AEON -0.02
- Stochastic Oscillator
- USEA 6.25
- AEON 19.08
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of seven dry bulk vessels, comprising three Panamax, two Capesize and two Kamsarmax vessels with an aggregate cargo-carrying capacity of approximately 750,758 dwt.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.